Tokyo, Nov. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059824) titled 'High dOse irradiation for Painful non-spinE bone metastasis' on Nov. 19.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - painful non-spine bone metastasis
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the pain-response and patient outcomes of high-dose radiotherapy for painful non-spine bone metastasis
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients scheduled to receive high-dose radiotherapy for pain palliation of non-spine bone metastasis
2) Patients aged 20 years or older at the time of obtaining consent
3) Patients who have provided written informed consent
Key exclusion criteria - 1) Patients for whom follow-up is expected to be difficult (e.g., those living far from the hospital or with a performance status of 4 or higher)
2) Patients who are concurrently enrolled in another clinical trial that does not allow duplicate registration
3) Patients deemed inappropriate for inclusion by the principal investigator for any other reason
Target Size - 100
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 11 Month 14 Day
Date of IRB - 2025 Year 11 Month 14 Day
Anticipated trial start date - 2025 Year 11 Month 19 Day
Last follow-up date - 2029 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068412
Disclaimer: Curated by HT Syndication.
